ClinicalTrials.govpublic full text
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
smoldering plasma cell myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454028
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.